dalteparin has been researched along with Anemia, Cooley's in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Hyperhomocysteinemia is a metabolic disorder caused by various enzyme defects in methionine metabolism." | 1.51 | Multifactorial Painful Leg Ulcers Due to Hyperhomocysteinemia, Plasminogen Activator Inhibitor-1 4G/5G Heterozygote Gene Mutation, and Beta Thalassemia Minor: A Case Report. ( Büyükbabani, N; Çaytemel, C; Topaloğlu Demir, F; Türkoğlu, Z; Uzuner, EG, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Çaytemel, C | 1 |
Topaloğlu Demir, F | 1 |
Büyükbabani, N | 1 |
Türkoğlu, Z | 1 |
Uzuner, EG | 1 |
1 other study available for dalteparin and Anemia, Cooley's
Article | Year |
---|---|
Multifactorial Painful Leg Ulcers Due to Hyperhomocysteinemia, Plasminogen Activator Inhibitor-1 4G/5G Heterozygote Gene Mutation, and Beta Thalassemia Minor: A Case Report.
Topics: Bandages; beta-Thalassemia; Biopsy; Diagnosis, Differential; Enoxaparin; Fibrinolytic Agents; Humans | 2019 |